日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature

病例报告:伴有t(3;12)(q26.2;p13.1)/MECOM-ETV6易位的髓系肿瘤:两例新病例报告及文献复习

Mikkilineni, Soumya; Pineda-Reyes, Juan Pablo; Wilde, Lindsay; Ferber, Andres; Wang, Zi-Xuan; Peiper, Stephen; Uppal, Guldeep; Gong, Jerald; Liu, Jinglan

Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

伊布替尼或阿卡替尼治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的真实世界安全性概况

Hafer, Ramsay; Iadevaia, Francesco; Rohan, Thomas Z; Duong, Teresa; Poluch, Maria; Keiffer, Gina; Li, Michael; Ferber, Andres; Laurenti, Luca; Khoo, Alan S; Porcu, Pierluigi

Results of an international survey on the current organization of care for pregnant women with cancer

一项关于当前癌症孕妇护理组织情况的国际调查结果

Heimovaara, Joosje H; van Calsteren, Kristel; Lok, Christianne A R; Evens, Andrew M; Hoegl, Jorge; Ferber, Andres; Fernandes, Andreina; Vriens, Ingeborg; van Zuylen, Lia; Amant, Frédéric

A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide

一例化疗难治性“结节性淋巴细胞为主型霍奇金淋巴瘤样转化”病例,采用来那度胺治疗后获得成功。

Siricilla, Mamatha; Irwin, Lydia; Ferber, Andres

A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study.

在健康受试者中,采用新型蛋白质生产系统(AVI-014)生产的糖基化重组人粒细胞集落刺激因子:首次人体单剂量对照研究

Varki Roslyn, Pequignot Ed, Leavitt Mark C, Ferber Andres, Kraft Walter K